A chewable multivitamin distributed across 25 states has been recalled after federal inspectors found the product contained lower‑than‑intended levels of vitamin D.
What To Know
The recall involves Multivitamin with Fluoride Chewable Tablets, Grape Flavor, according to FDA records.
The product was manufactured by Winder Laboratories, LLC, based in Winder, Georgia.
Newsweek called Winder Laboratories, LLC, and left a voicemail on Saturday morning seeking comment.
Two versions of the multivitamin are affected. One contains 0.25 mg fluoride in bottles of 100 tablets with NDC 75826‑169‑10 and UPC 3 15826 16910 2.
The second contains 1.0 mg fluoride, also in 100‑tablet bottles, with NDC 75826‑171‑10 and UPC 3 15826 17110 5.
The recall was initiated after a U.S. Food and Drug Administration (FDA) inspection found the product was subpotent for vitamin D, meaning it contained less of the vitamin than intended.
Vitamin D plays a key role in bone health by helping the body absorb calcium, and it also supports the immune system. Getting enough of it helps maintain overall health, particularly for bones and muscles.
The issue prompted a voluntary recall by the manufacturer.
FDA records show the recall affects 422 cases of the 0.25 mg product and 210 cases of the 1.0 mg product, with each case containing 12 bottles of 100 tablets.
Impacted products can be identified by the following lot information:
- Lot 1692303, serial number 138909557498, expiration date October 26, 2025
- Lot 1692304, serial number 131163901709, expiration date October 26, 2025
- Lot 1712301, serial number 163590222021, expiration date November 14, 2025
The recall is listed under recall number H‑0569‑2026 and is associated with FDA Event ID 97884.
According to the agency, initial notifications of the recall were sent by letter.
Distribution records show the product was shipped to 25 states and territories, including Alabama, Arizona, California, Florida, Hawaii, Iowa, Illinois, Indiana, Massachusetts, Michigan, Missouri, Mississippi, North Carolina, New Jersey, New York, Oregon, Pennsylvania, Puerto Rico, Rhode Island, Tennessee, Texas, Utah, Washington, Wisconsin, and West Virginia.
The recall was initiated on October 27, 2025, and the FDA assigned its risk classification on March 13, 2026.
It remains ongoing, and no termination date has been listed.
What Is a Class III Recall?
The FDA classified the multivitamin recall as Class III, the agency’s lowest risk category.
A Class III recall is used when use of or exposure to a product is not likely to cause adverse health consequences, but the product still violates FDA regulations.
In this case, the classification reflects the FDA’s assessment that the subpotency issue does not pose a significant health risk, while still requiring corrective action.
